Luc Verhelst
Technik-/Wissenschafts-/F&E-Leiter bei The European Medicines Agency
Ursprung des Netzwerks ersten Grades von Luc Verhelst
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
The European Medicines Agency
49
| Government | National Agency | 49 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Luc Verhelst
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Transmit Security, Inc.
 Transmit Security, Inc. Packaged SoftwareTechnology Services Transmit Security connects applications to authenticators like face recognition, eye recognition, voice recognition, fingerprint and OTP services. It provides device binding, primary, secondary authentication and respond to security risks immediately services. The company was founded in 2014 by Rakesh K. Loonkar and Mickey Boodaei and is headquartered in Newton, MA. | Packaged Software | Corporate Officer/Principal | |
| AERCAP HOLDINGS N.V. | Finance/Rental/Leasing | Chief Tech/Sci/R&D Officer | |
| Università degli Studi di Modena e Reggio Emilia | College/University | Corporate Officer/Principal | |
| Vera SCI | Corporate Officer/Principal | ||
| Agenzia Italiana del Farmaco | Chief Executive Officer | ||
| NETRAMARK HOLDINGS INC. | Packaged Software | General Counsel | |
| Asklepios Medicin Handelsbolag | Corporate Officer/Principal | ||
| University of Oxford | College/University | Corporate Officer/Principal | |
| The University of Manchester | College/University | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member | |
| The Federation of Veterinarians of Europe | Corporate Officer/Principal | ||
| Plymouth State University | College/University | Undergraduate Degree | |
| JUNIPER NETWORKS, INC. | Information Technology Services | Corporate Officer/Principal | |
Sanofi-Aventis Ltd.
 Sanofi-Aventis Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Ltd. provides pharmaceutical services. It focuses on cardiovascular medicine, thrombosis, oncology, metabolic disorders and diseases of the central nervous system. The company was founded in December 2004 and is headquartered in Guildford, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
| EMC CORPORATION | Computer Peripherals | Sales & Marketing | |
| NUTANIX, INC. | Packaged Software | Corporate Officer/Principal | |
| Medicines & Healthcare Products Regulatory Agency | General Government | Chief Executive Officer | |
| The American University of Rome | College/University | Undergraduate Degree | |
GT-Solar GmbH
 GT-Solar GmbH Electrical ProductsProducer Manufacturing Since 1995, GT-SOLAR GmbH installed solar power systems. Their products for solar power systems meet the highest quality and service guidelines established manufacturers. Due to the long investment capacity of over 30 years for photovoltaic systems, they offer exclusively to items which are technically up to date. Their cases, they have developed and certified by TUV Rheinland. Through careful selection of their suppliers, they make sure that warranty and guarantee claims made for many years. Through the consistent implementation of their quality and cost-efficient products you will secure the longevity and profitability of your solar system. | Electrical Products | Sales & Marketing | |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | President | |
Chronos Therapeutics Ltd.
 Chronos Therapeutics Ltd. BiotechnologyHealth Technology Chronos Therapeutics Ltd. manufactures drugs. It pursuing innovative therapeutics for age-related diseases through the joint efforts of experts in medical research, drug discovery and business development. The company was founded in 2009 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
Porton Biopharma Ltd.
 Porton Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Porton Biopharma Ltd. is a biopharmaceutical company based in Salisbury, UK. The British company is focused on the development and manufacture of biopharmaceutical products for the treatment of infectious diseases and cancer. Porton Biopharma is committed to delivering high-quality products that meet the needs of patients and healthcare providers. The CEO of the private company is Roger Hinton, who leads a team of experienced professionals dedicated to advancing the company's mission. | Pharmaceuticals: Major | Director/Board Member | |
| DESTINY PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
Clinical Insights Ltd.
 Clinical Insights Ltd. Miscellaneous Commercial ServicesCommercial Services Clinical Insights Ltd. engages in the provision of advisory services to the pharmaceutical industry. The company is headquartered in Milan, Italy. | Miscellaneous Commercial Services | Chairman | |
Pertinax Pharma Ltd.
 Pertinax Pharma Ltd. Pharmaceuticals: MajorHealth Technology Pertinax Pharma Ltd. manufactures pharmaceutical products. developing medical, healthcare and veterinary applications of a novel, proprietary long acting formulation of the already widely used antimicrobial drug chlorhexidine. Pertinax Pharma was founded by Michele Barbour in 2015 and is headquartered in Bristol, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| Industrial Development Advisory Board | Director/Board Member | ||
| Carlow Institute of Technology | College/University | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 12 |
| Vereinigte Staaten | 7 |
| Italien | 5 |
| Schweden | 4 |
| Irland | 3 |
Sektoral
| Health Technology | 9 |
| Consumer Services | 8 |
| Technology Services | 5 |
| Commercial Services | 3 |
| Finance | 2 |
Operativ
| Corporate Officer/Principal | 52 |
| Director/Board Member | 13 |
| Chairman | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nigel Brooksby | 11 |
| Christopher Kaddaras | 6 |
| Jonas Bergh | 6 |
| Luca Pani | 5 |
| John Burke | 3 |
| Guido Rasi | 2 |
| Andreas Pott | 2 |
| Nancy De Briyne | 2 |
| Kent Woods | 2 |
| Patrick Le Courtois | 1 |
| Amanda Johannson | 1 |
| Paolo Alcini | 1 |
| Sylvie Beausuroy | 1 |
| Henri Meyer | 1 |
| Guy Fiems | 1 |
- Börse
- Insiders
- Luc Verhelst
- Unternehmensverbindungen
